Member Info for WeTookPelham

https://www.independent.co.uk/news/health/covid-uk-cases-today-nhs-vaccine-latest-b2098253.html

"Covid news – live: ‘New wave is now starting’ Sage expert warns as UK infections rise
Omicron variants likely caused the recent jump in cases, new data suggests"

Looks like you're not the only one, a sudden influx?

Also...myself and others did say they're could be multiple RNSs this week. The radio silence was far too extended IMO but we could all see lots was going in the background.

Mine should have been a cheeky big buy rather than a cheeky little one! Hindsight huh!

Thanks crumbs. I wouldn't say no to a big money deal on early data! But yes you'd think any potential partner would want to secure a deal sooner rather than later?

So another one of my ill thought out questions so apologies in advance.

But, if we assume trial results/feedback from Moditope can happen quickly(?), and we assume (a big assumption??) Scancell have had long standing conversations with potential partners for Moditope, how quickly could things move forward? And what would be the sequence of events I.e. moving on to the next test phase? Would potential partners be privy to the information as the trials are being conducted i.e via an NDA? etc.

Told you it was ill thought out.

...a cheeky little top up now the price seems to have settled a little.
As mentioned by others, could there be another RNS this week...

Yep terrible day on the overall markets which I'm sure is having an impact here on the SP, however it seems for Scancell (uniquely) that significant, game changing news seems to regularly attract just a "meh" response to the SP? Most peculiar IMO.

...normal service has resumed.

I guess the usual pattern is some tweets following every RNS, but as mentioned I think it's interesting that they haven't this time, so far anyway...more important things to do perhaps? So I don't think anything to be concerned about, the opposite in fact.

The RNS has all the info anyway.

RE four companies, I always wondered if who they follow on Twitter gave us a clue.

The UK now as well it seems:
https://www.bbc.co.uk/news/health-61758570

How many shares was that for Roses? I managed to get a quote close to the close for a tiny 1000 shares, but at 12.975p however.

An interesting close nonetheless. Wonder if we'll see a large delayed buy that was causing your buys to be denied at the time?

Too premature to say "wouldn't want to be out of this over the weekend!" ?? :)

Thanks Chester for update, it did look like a bed & ISA but always good to get clarification.
So those earlier, seperate 100k and 148k trades are looking like normal buys then? There's been some decent buying this week it seems.

The Guardian: Concern grows as two new Omicron sub-variants spread across US.
https://www.theguardian.com/world/2022/jun/08/new-omicron-sub-variants-ba4-ba5-coronavirus

Top work JohnnyB1.

...Nice to see.
P.S. Ray, hope you didn't forget to flush.

How is this a leak? Isn't it an update to the trial protocol to the relevant authorities?

Anyway...RE no RNS, is it a case the authorities get updated first? Also as mentioned by myself and others could the lack of any RNS's so far be down to contractual reasons?

@bazookajr - what are the updates exactly? I know you can compare versions but forget how.

...some interesting deals/M&A activity:

https://pipelinereview.com/index.php/2022060280962/More-News/Repare-Therapeutics-Announces-a-Worldwide-License-and-Collaboration-Agreement-with-Roche-for-Camonsertib-RP-3500.html

https://www.biopharma-reporter.com/Article/2022/06/02/Regeneron-purchases-Sanofi-s-stake-in-Libtayo-collaboration